Pulmatrix Inc (NASDAQ: PULM), a Clinical Stage Biopharmaceutical Company developing inhaled therapies for the treatment of pulmonary diseases, announced the signing of a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson (NYSE: JNJ), enabling the initiative to access the Company’s...
Paratek Pharmaceuticals (NASDAQ: PRTK), a commercial-stage biopharmaceutical Company, announced the withdrawal of its submission to the European Medicines Agency (EMA), for the grant of Marketing Authorization Application (MAA) for NUZYRA® (omadacycline). The Company was developing the candidate for two indications namely, acute bacterial skin and...
A rare genetic disorder caused by the accumulation of glucocerebroside in cells of the macrophage-monocyte system, owing to the lack of the glucocerebrosidase enzyme, Gaucher primarily affects the liver and the spleen. The disease manifests as Type 1, the most common form, also known as...
Rosacea affects over 415 million people worldwide, and more than 16 million in the U.S alone, according to research conducted by the University of Copenhagen, Denmark. It is a fairly common skin disorder, but only 18 percent of Americans afflicted with this condition are under...
Crohn’s is an inflammatory bowel disease characterized by chronic inflammation of the gastrointestinal tract, chronic diarrhea, abdominal cramps, rectal bleeding and constipation to name a few. It is estimated that Crohn’s disease affects 780,000 Americans, with the highest prevalence being between the ages of 15...
Gonorrhoea, caused by a bacterial pathogen N. gonorrhoea, is the second most commonly reported sexually transmitted disease in the U.S alone. The data made available by Centres for Disease Control and Prevention (CDC) shows that in 2017, a total of 555,608 cases of gonorrhoea were reported...
